Interview with Günter Cseh, General Manager, Meda Pharma Austria
What have been the most significant developments as a result of the acquisition of Viatris by Meda Pharma in 2005? At that time Viatris was a small company, and there…
Address: Guglgasse 15/II. Stock, 1110 Vienna,Austria
Tel: +43 + (1) 86390-0
Web: http://www.meda.at/content/home/index.php
Meda is a leading specialty pharmaceutical company in Europe that offers cost-oriented medicine and the medical need. With offices in 26 countries Meda covers almost the whole of Europe. In other world markets, the pharmaceuticals are marketed by Meda and other representatives of pharmaceutical companies and sold.
Meda focuses on the treatment areas asthma & allergies, cardiovascular disease, pain and inflammation, gastroenterology and dermatology & infections.
Meda Pharma GmbH with its headquarters in Vienna (see photo) is a subsidiary of Meda AB., Sweden. Meda Pharma Austria looks back on a long company history, what with the PANCHEMIE HOMBURG found its founding. Subsequently developed into ASTA MEDICA Arzneimittel GmbH, which was renamed in 2002 in VIATRIS Pharma GmbH and since October 2005, owned by the Swedish pharmaceutical company Meda is.
Meda Pharma GmbH Austria continues its focus on products for the therapy and treatment of respiratory diseases (Novolizer ®, Allergodil ®), pain (Adamon ®) for the prevention and treatment of osteoporosis (Maxi-Kalz ®), treatment of cardiovascular disease (Magnosolv ®, Aquaphoril ®) and a specific complication of diabetes mellitus (Thioctacid ®), as well as therapeutic agents for use in the Department of Gynecology (Cyklokapron ® Ftbl., Estrogel ®, Utrogestan ®, Parlodel ®). Another therapeutic area of Meda Pharma, the treatment of skin diseases, such as the actinic keratoses, basal cell carcinomas or genital warts (Aldara ®). The innovative nutritional supplements Longeva ® completes the product range.
Furthermore, there are good pharmacy products such as Ce-soda ®, Histaxin ®, and Kamillosan Travelgum ® and the dietary supplement Osteo-Active ® and Magnofit ® – pellets in the product portfolio of Meda Austria.
What have been the most significant developments as a result of the acquisition of Viatris by Meda Pharma in 2005? At that time Viatris was a small company, and there…
Ard van der Meij, country president of Novartis Group Austria, the nation’s leading pharmaceutical company, discusses the advantages in Austria for innovative companies and the steps required to bolster the…
Prof. Dr. Robin Rumler, country manager of Pfizer Austria, discusses the evolution of their operations, especially since taking over the TBE and meningitis vaccine production plant, as well as the…
Austria has long been merely a cog in the wheel of global R&D, lying in the shadows of neighboring research giants, Germany and Switzerland. Now, however, this perception is changing…
Dr. Sabine Mӧritz-Kaisergruber and Helmut Kaisergruber, CEOs of Astro Pharma, a young vibrant Austrian pharmaceutical company, discuss their tailored strategy to establish themselves within the Austrian market as well as…
Clemens Schödl, general manager of Gilead Austria, discusses Gilead’s footprint and reputation in Austria as the leading global player in HIV treatment and what must be done to bring Austrian…
Siegfried Leitner, general manager of Accord Austria and Germany, and CEO and co-founder of A-med, provides an insight into the early years of his Accord affiliate and how it was…
Robert Sauermann, head of the department of pharmaceutical affairs in the Main Association of Austrian Social Security Institutions, which publishes the national code of reimbursement, provides an in-depth look into…
Dr. Jan Oliver Huber, secretary general of the Association of the Pharmaceutical Industry in Austria, or PHARMIG, which represents 120 member companies and 95 percent of the medicinal product market…
Martin Peithner, CEO of Dr. Peithner and Austroplant, two leading medical companies focusing on homeopathic and herbal medicines in Austria, discusses the evolution of the companies over the last five…
Arnoldas Doviltis, general manager of Ferring Austria, a research-driven Swiss biopharmaceutical company, elaborates on the autonomous nature of local Ferring affiliates and how this allows a tailored approach to conduct…
Eva Bano, CEO of BANO, an exciting west Austrian company, discusses the company’s modern revamp and expansion from natural therapies to pharmaceutical products. She also explains the importance of a…
Erich Lehner, head of the life science branch at EY Austria, a worldwide leading consultancy firm, provides an insight into the current mandate of EY Austria as well as the…
See our Cookie Privacy Policy Here